At a glance
ClinicalIndex Comparison RecordN/ACompleted· 185 enrolled
Drug / intervention
Procalcitonin lab testother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Procalcitonin at Zero and 24 Hours as a Prognostic Factor in Patients With Pneumonia
In Brief
An observational study evaluating Procalcitonin lab test for Pneumonia. Completed, enrolled 185 participants across 1 site.
Detailed Summary
Procalcitonin levels checked initially and at 24 hours will correlate with disease severity, morbidity, and mortality. Patients who have a higher procalcitonin level initially and at 24 hours will likely have higher qSOFA scores, longer lengths of stay, longer duration of antibiotics and higher 30 day mortality rates.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPneumonia
CountriesUnited States
CollaboratorsMichigan State University
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartJul 2018
First PostedOct 2018
Primary CompletionAug 2019
TodayJul 2026
First PostedOct 18, 2018
Enrollment StartJul 17, 2018
Primary CompletionAug 1, 2019
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 7.7 years ago
Interventions
Procalcitonin lab testother
A procalcitonin order bundle will be created for admitted patients with pneumonia. This prepopulated bundle includes an initial and 24 hour procalcitonin level.